Búsqueda | Biblioteca Virtual en Salud

1.

Congenital dysfibrinogenemia: fibrinogen Detroit.

Mammen, E F; Prasad, A S; Barnhart, M I; Au, C C.

J Clin Invest ; 48(2): 235-49, 1969 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-4974308

2.

Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.

Timmis, G C; Mammen, E F; Ramos, R G; Gordon, S; Gangadharan, V; Hauser, A M; Westveer, D C; Stewart, J R.

Arch Intern Med ; 146(4): 667-72, 1986 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-3963947

3.

Absolute and comparative subcutaneous bioavailability of ardeparin sodium, a low molecular weight heparin.

Troy, S; Fruncillo, R; Ozawa, T; Mammen, E; Holloway, S; Chiang, S.

Thromb Haemost ; 78(2): 871-5, 1997 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-9268187

4.

Usefulness of subcutaneous low molecular weight heparin (ardeparin) for reduction of restenosis after percutaneous transluminal coronary angioplasty.

Gimple, L W; Herrmann, H C; Winniford, M; Mammen, E.

Am J Cardiol ; 83(11): 1524-9, 1999 Jun 01.

Artículo en Inglés | MEDLINE | ID: mdl-10363865

5.

Platelet hyperaggregability in patients with chest pain and angiographically normal coronary arteries.

Rubenfire, M; Blevins, R D; Barnhart, M; Housholder, S; Selik, N; Mammen, E F.

Am J Cardiol ; 57(8): 657-60, 1986 Mar 01.

Artículo en Inglés | MEDLINE | ID: mdl-3953453

6.

Circadian variation in platelet function in healthy volunteers.

Jafri, S M; VanRollins, M; Ozawa, T; Mammen, E F; Goldberg, A D; Goldstein, S.

Am J Cardiol ; 69(9): 951-4, 1992 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-1532287

7.

Pathogenesis of venous thrombosis.

Mammen, E F.

Chest ; 102(6 Suppl): 640S-644S, 1992 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-1451539

8.

Determination of low-molecular-weight heparin by Heptest on the automated coagulation laboratory system.

Ozawa, T; Domagalski, J; Mammen, E F.

Am J Clin Pathol ; 99(2): 157-62, 1993 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-8438788

9.

Perspectives for the future.

Mammen, E F.

Intensive Care Med ; 19 Suppl 1: S29-34, 1993.

Artículo en Inglés | MEDLINE | ID: mdl-8227736

10.

Serial changes in primary hemostasis after massive transfusion.

Harrigan, C; Lucas, C E; Ledgerwood, A M; Walz, D A; Mammen, E F.

Surgery ; 98(4): 836-44, 1985 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-4049256

11.

Permanent in-series cardiac assistance with the dynamic aortic patch: Blood-prosthesis interaction in long-term canine experiments.

Schraut, W; Kiso, I; Freed, P; Baechler, C; Barnhart, M; Riddle, J; Mammen, E; Mandell, G; Kantrowitz, A.

Surgery ; 79(02): 193-201, 1976 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-128839

12.

Increased intravascular coagulation associated with pregnancy.

Gerbasi, F R; Bottoms, S; Farag, A; Mammen, E.

Obstet Gynecol ; 75(3 Pt 1): 385-9, 1990 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-2137574

13.

Hemostasis in hypertensive disorders of pregnancy.

Saleh, A A; Bottoms, S F; Norman, G; Farag, A; Mammen, E F.

Obstet Gynecol ; 71(5): 719-22, 1988 May.

Artículo en Inglés | MEDLINE | ID: mdl-2451798

14.

Oral contraceptives and the hemostatic system.

Farag, A M; Bottoms, S F; Mammen, E F; Hosni, M A; Ali, A A; Moghissi, K S.

Obstet Gynecol ; 71(4): 584-8, 1988 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-3353050

15.

Antithrombin, prekallikrein, and fibronectin levels in surgical patients.

Wilson, R F; Mammen, E F; Robson, M C; Heggers, J P; Soullier, G; DePoli, P A.

Arch Surg ; 121(6): 635-40, 1986 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-3486649

16.

The dose proportionality of the pharmacokinetics of ardeparin, a low molecular weight heparin, in healthy volunteers.

Troy, S; Fruncillo, R; Ozawa, T; Mammen, E; Holloway, S; Chiang, S.

J Clin Pharmacol ; 35(12): 1194-9, 1995 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-8750371

17.

Coagulation abnormalities in liver disease.

Mammen, E F.

Hematol Oncol Clin North Am ; 6(6): 1247-57, 1992 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-1333467

18.

Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease.

Mammen, E F.

Hematol Oncol Clin North Am ; 14(5): 1045-59, vii-viii, 2000 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-11005033

19.

In vitro platelet function in controlled ovarian hyperstimulation cycles.

Richard-Davis, G; Montgomery-Rice, V; Mammen, E F; Alshameeri, R S; Morgan, D; Moghissi, K S.

Fertil Steril ; 67(5): 923-7, 1997 May.

Artículo en Inglés | MEDLINE | ID: mdl-9130901

20.

Performance characteristics and clinical evaluation of an in vitro bleeding time device--Thrombostat 4000.

Alshameeri, R S; Mammen, E F.

Thromb Res ; 79(3): 275-87, 1995 Aug 01.

Artículo en Inglés | MEDLINE | ID: mdl-8533123

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Congenital dysfibrinogenemia: fibrinogen Detroit.

Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.

Absolute and comparative subcutaneous bioavailability of ardeparin sodium, a low molecular weight heparin.

Usefulness of subcutaneous low molecular weight heparin (ardeparin) for reduction of restenosis after percutaneous transluminal coronary angioplasty.

Platelet hyperaggregability in patients with chest pain and angiographically normal coronary arteries.

Circadian variation in platelet function in healthy volunteers.

Pathogenesis of venous thrombosis.

Determination of low-molecular-weight heparin by Heptest on the automated coagulation laboratory system.

Perspectives for the future.

Serial changes in primary hemostasis after massive transfusion.

Permanent in-series cardiac assistance with the dynamic aortic patch: Blood-prosthesis interaction in long-term canine experiments.

Increased intravascular coagulation associated with pregnancy.

Hemostasis in hypertensive disorders of pregnancy.

Oral contraceptives and the hemostatic system.

Antithrombin, prekallikrein, and fibronectin levels in surgical patients.

The dose proportionality of the pharmacokinetics of ardeparin, a low molecular weight heparin, in healthy volunteers.

Coagulation abnormalities in liver disease.

Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease.

In vitro platelet function in controlled ovarian hyperstimulation cycles.

Performance characteristics and clinical evaluation of an in vitro bleeding time device--Thrombostat 4000.